New study aims to sharpen lung cancer staging, spare patients unnecessary surgery

NCT ID NCT01786590

Recruiting now Diagnosis Sponsor: University Health Network, Toronto Source: ClinicalTrials.gov ↗

First seen May 08, 2026 · Last updated May 08, 2026 · Updated 1 time

Summary

This study compares two ways to check if lung cancer has spread to lymph nodes in the chest: a standard CT/PET scan versus a minimally invasive scope test called EBUS-TBNA. The goal is to see which method is more accurate for patients with early-stage non-small cell lung cancer who are scheduled for a precise type of radiation (SBRT). About 150 adults with confirmed lung cancer will take part. Better staging could help more high-risk patients get effective, less invasive treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Toronto General Hospital
RECRUITING

Toronto, Ontario, M5G 1L7, Canada

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

LUNG CANCER